Ghaith Aljayyoussi

10PUBLICATIONS
69CO-AUTHORS
Infectious diseasesPharmacogenomicsMolecular medicineMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 13, 2025
Comparison of the analytical and clinical sensitivities of 34 rapid antigen tests with prevalent SARS-CoV-2 variants of concern during the COVID-19 pandemic in the UK.

Rachel L Byrne, Rachel S Owen, Ghaith Aljayyoussi

|Mar 17, 2025
Predicting Pharmacokinetics in Rats Using Machine Learning: A Comparative Study Between Empirical, Compartmental, and PBPK-Based Approaches.

Moritz Walter, Ghaith Aljayyoussi, Bettina Gerner

|Oct 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis.

Rajith K R Rajoli, Henry Pertinez, Usman Arshad

|Jun 09, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis.

Rajith Kr Rajoli, Henry Pertinez, Usman Arshad

|May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.

Usman Arshad, Henry Pertinez, Helen Box

|Jun 16, 2019
Intracellular PD Modelling (<i>PD</i><sub>i</sub>) for the Prediction of Clinical Activity of Increased Rifampicin Dosing.

Ghaith Aljayyoussi, Samantha Donnellan, Stephen A Ward

Pageof 2

Frequent Collaborators

4 joint publications

Steve Ward

3 joint publications

Paul Curley

3 joint publications

Megan Neary

3 joint publications

Andrew Owen